An Insulin‐Sensitizing Thiazolidinedione, Which Minimally Activates PPARγ, Does Not Cause Bone Loss

E-ISSN： 1523-4681|30|3|508-515

ISSN： 0884-0431

Source： JOURNAL OF BONE AND MINERAL RESEARCH, Vol.30, Iss.3, 2015-03, pp. : 508-515

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Insulin and Insulin-Sensitizing Drugs in Neurodegeneration: Mitochondria as Therapeutic Targets

By Cardoso Susana Santos Renato Correia Sonia Carvalho Cristina Zhu Xiongwei Lee Hyoung-Gon Casadesus Gemma Smith Mark A. Perry George Moreira Paula I.

Pharmaceuticals, Vol. 2, Iss. 3, 2009-12 ,pp. : 250-286

MDPI

Access to resources Recommend Favorite

Insulin-sensitizing agents: use in pregnancy and as therapy in polycystic ovary syndrome

By Checa M.A.

Human Reproduction Update, Vol. 11, Iss. 4, 2005-07 ,pp. : 375-390

Oxford University Press

Access to resources Recommend Favorite

Insulin sensitizing drugs for weight loss in women of reproductive age who are overweight or obese: systematic review and meta-analysis

By Nieuwenhuis-Ruifrok A.E. Kuchenbecker W.K.H. Hoek A. Middleton P. Norman R.J.

Human Reproduction Update, Vol. 15, Iss. 1, 2009-01 ,pp. : 57-68

Oxford University Press

Access to resources Recommend Favorite

Effects of placebo‐controlled insulin‐sensitizing drugs on hormonal parameters in polycystic ovary syndrome patients: A network meta‐analysis

JOURNAL OF CELLULAR BIOCHEMISTRY, Vol. 119, Iss. 3, 2018-03 ,pp. : 2501-2511

John Wiley & Sons Inc

Access to resources Recommend Favorite

Insulin-Sensitizing Effect of LXR Agonist T0901317 in High-Fat Fed Rats is Associated with Restored Muscle GLUT4 Expression and Insulin-Stimulated AS160 Phosphorylation

Cellular Physiology and Biochemistry, Vol. 33, Iss. 4, 2014-04 ,pp. : 1047-1057

Karger

Access to resources Recommend Favorite